Moody's
MCO
Coca-Cola
KO
VeriSign
VRSN
MasterCard
MA
DaVita
DVA
US Stock MarketDetailed Quotes
BTTX Better Therapeutics
- 0.000
- 0.0000.00%
15min DelayClose Dec 31 16:00 ET
5.45KMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)54.52MShares0.25052wk High0.00P/B2.42KFloat Cap0.00052wk Low--Dividend TTM24.24MShs Float29.400Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Better Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.25%-5.94M | 24.37%-5.09M | 1.57%-8.72M | 6.13%-28.93M | 60.02%-6.34M | -2.10%-7.01M | -22.69%-6.73M | -238.36%-8.86M | -433.74%-30.82M | -15.85M |
| Net income from continuing operations | 48.60%-5.86M | 23.56%-7.59M | 3.16%-9.36M | 1.43%-39.76M | 36.92%-8.77M | 8.47%-11.41M | -14.77%-9.93M | -81.28%-9.66M | -531.52%-40.34M | ---13.89M |
| Depreciation and amortization | 21.18%841K | 22.43%797K | 13.88%755K | 68.56%2.73M | 30.85%721K | 31.94%694K | 23.76%651K | 4,043.75%663K | 2,058.67%1.62M | --551K |
| Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-152K | --0 |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,255.03%9.74M | --1.61M |
| Change In working capital | -143.64%-1.35M | -42.93%1.23M | -126.84%-524K | 367.98%6.27M | 126.88%1.26M | 95.88%3.09M | 388.64%2.15M | -171.52%-231K | -864.38%-2.34M | ---4.68M |
| -Change in prepaid assets | -62.09%480K | 8.82%1.15M | -72.80%337K | 144.20%2.04M | 42.41%-1.52M | 290.66%1.27M | 249.65%1.06M | 305.47%1.24M | -8,642.59%-4.61M | ---2.64M |
| -Change in payables and accrued expense | -200.22%-1.83M | -92.79%79K | 41.43%-861K | 85.97%4.23M | 236.29%2.78M | -18.60%1.83M | -4.37%1.1M | -258.75%-1.47M | 802.38%2.27M | ---2.04M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.25%-5.94M | 24.37%-5.09M | 1.57%-8.72M | 6.13%-28.93M | 60.02%-6.34M | -2.10%-7.01M | -22.69%-6.73M | -238.36%-8.86M | -433.74%-30.82M | ---15.85M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 117.65%66K | -23.59%-503K | -1,235.90%-521K | -10.18%-1.18M | 23.73%-360K | -1,977.78%-374K | -40,800.00%-407K | 93.30%-39K | 53.54%-1.07M | -472K |
| Capital expenditure reported | 120.23%71K | -33.42%-503K | ---495K | -5.71%-1.07M | 20.46%-346K | ---351K | -37,800.00%-377K | --0 | 55.59%-1.02M | ---435K |
| Net PPE purchase and sale | 78.26%-5K | --0 | 33.33%-26K | -92.73%-106K | 62.16%-14K | -27.78%-23K | ---30K | ---39K | -223.53%-55K | ---37K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 117.65%66K | -23.59%-503K | -1,235.90%-521K | -10.18%-1.18M | 23.73%-360K | -1,977.78%-374K | -40,800.00%-407K | 93.30%-39K | 53.54%-1.07M | ---472K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 104,550.00%6.28M | 11.14%5.72M | -43,600.00%-435K | -92.69%5.28M | -99.75%132K | -99.93%6K | -14.25%5.15M | -99.98%1K | 871.55%72.33M | 53.66M |
| Net issuance payments of debt | --0 | -108.46%-423K | ---435K | -82.56%5M | --0 | --0 | -16.67%5M | --0 | 285.16%28.68M | --10M |
| Proceeds from stock option exercised by employees | --0 | -71.72%41K | --0 | -99.52%284K | -99.78%132K | --6K | --145K | --1K | --59.05M | --59.05M |
| Net other financing activities | ---444K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---15.39M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 104,550.00%6.28M | 11.14%5.72M | -43,600.00%-435K | -92.69%5.28M | -99.75%132K | -99.93%6K | -14.25%5.15M | -99.98%1K | 871.55%72.33M | --53.66M |
| Net cash flow | ||||||||||
| Beginning cash position | -79.13%6.2M | -80.84%6.07M | -61.20%15.74M | 32,880.49%40.57M | 590.13%22.31M | 1,301.56%29.69M | 1,880.80%31.67M | 32,880.49%40.57M | -83.75%123K | --3.23M |
| Current changes in cash | 105.45%402K | 106.44%128K | -8.76%-9.67M | -161.39%-24.83M | -117.58%-6.57M | -762.48%-7.38M | -483.04%-1.99M | -702.51%-8.89M | 6,479.02%40.44M | --37.33M |
| End cash Position | -70.42%6.6M | -79.13%6.2M | -80.84%6.07M | -61.20%15.74M | -61.20%15.74M | 590.13%22.31M | 1,301.56%29.69M | 1,880.80%31.67M | 32,880.49%40.57M | --40.57M |
| Free cash flow | 20.43%-5.88M | 21.63%-5.59M | -3.86%-9.24M | 5.58%-30.11M | 58.97%-6.7M | -7.26%-7.39M | -30.14%-7.13M | -178.02%-8.89M | -294.71%-31.89M | ---16.32M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.